ScholarIQanswers from OpenAlex
DBV Technologies (France)
InstitutionResearch output, impact & collaborations
DBV Technologies (France) is a institution indexed in ScholarIQ from OpenAlex.
What is known about DBV Technologies (France)?
ScholarIQrecord summary
DBV Technologies (France) is a research organisation in Bagneux, FR. OpenAlex records 292 works and 15,144 citations for it.
How many works does DBV Technologies (France) have?
ScholarIQindexed works
DBV Technologies (France) has 292 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does DBV Technologies (France) have?
ScholarIQcitation count
DBV Technologies (France) has 15,144 citations in the OpenAlex counts ScholarIQ stores.
What is the average h-index at DBV Technologies (France)?
ScholarIQavg h-index
DBV Technologies (France) has an average h-index of 11 in OpenAlex.
What is the ROR of DBV Technologies (France)?
ScholarIQror
The ROR for DBV Technologies (France) is on the source record.
What is the OpenAlex record for DBV Technologies (France)?
ScholarIQopenalex
The OpenAlex for DBV Technologies (France) is on the source record.
Who are the most-cited researchers behind DBV Technologies (France)?
ScholarIQtop researchers by citations
What are the most-cited papers on DBV Technologies (France)?
ScholarIQmost cited works
Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes
James A. de Lemos, Michael A. Blazing, Stephen D. Wiviott, Eldrin F. Lewis, Keith A.A. Fox, Harvey D. White, Jean‐Lucien Rouleau, Terje R. Pedersen, Laura H. Gardner, Robin Mukherjee, Karen E. Ramsey, Joanne Palmisano, David W. Bilheimer, Marc A. Pfeffer, Robert M. Califf, Eugene Braunwald, for the ASTEROID Investigators
Selective Aldosterone Blockade with Eplerenone Reduces Albuminuria in Patients with Type 2 Diabetes
Murray Epstein, Gordon H. Williams, Myron H. Weinberger, Andrew Lewin, Scott Krause, Robin Mukherjee, Rajiv Patni, Bruce Beckerman
Eplerenone Reduces Mortality 30 Days After Randomization Following Acute Myocardial Infarction in Patients With Left Ventricular Systolic Dysfunction and Heart Failure
Bertram Pitt, Harvey D. White, José Carlos Nicolau, Felipe A. Martínez, Mihai Gheorghiade, Michael Aschermann, Dirk J. van Veldhuisen, Faı̈ez Zannad, Henry Krum, Robin Mukherjee, John Vincent
Serum Potassium and Clinical Outcomes in the Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)
Bertram Pitt, George L. Bakris, Luís M. Ruilope, Lorenzo A. DiCarlo, Robin Mukherjee
Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study
Marc Cohen, Pierre Théroux, Steven Borzak, Martin J. Frey, Harvey D. White, W. Van Mieghem, Fred Senatore, Joy Lis, Robin Mukherjee, Kathy Harris, Frédérique Bigonzi
How much of the research on DBV Technologies (France) is open access?
ScholarIQopen access share
60%OPEN ACCESS